Contact this trialFirst, we need to learn more about you.
Recombinant Fusion Protein
MT-5111 for Solid Cancers
Recruiting1 awardPhase 1
Phoenix, Arizona
This trial will test a new protein drug in people with HER2-positive cancer. The drug will be given alone to see how well it works and what dose is safe.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.